CARDIAC SCIENCE (NASDAQ:CSCX)
2.23
-0 (-0%)
| CARDIAC SCIENCE (NASDAQ:CSCX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $8.10 | ||
| Open | $2.25 | 52 Week Low | $2.12 | ||
| Day High | $2.37 | P/E | N/A | ||
| Day Low | $2.10 | EPS | $-7.55 | ||
| Volume | 296,435 | ||||
| More CSCX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| RAX | 3 | FRPT | 3 |
| CPST | 3 | AXAS | 2 |
| MR | 2 | FLL | 2 |
| LGF | 2 | FLR | 2 |
| NLS | 2 | CCO | 2 |
| SATS | 2 | NNI | 2 |
Entities who have mentioned CSCX
- Facebook | View Related Stories »
- Twitter | View Related Stories »
- Needham & Co | View Related Stories »
- Trading Radar | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Scopia Capital | View Related Stories »
- Standard & Poor's | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Deutsche Bank | View Related Stories »
- Robert W Baird | View Related Stories »
- After-Hours Movers | View Related Stories »
- Canaccord Adams | View Related Stories »
- HSBC | View Related Stories »
View All Major News StreetInsider.com Major News for CSCX
- Cardiac Science (CSCX) Reports Large Q3 Loss; Issues Mixed Guidance for Q4
- Cardiac Science (CSCX) Misses Q2 EPS by 4c; Guides Below for Q3
- Cardiac Science (CSCX) Reports Q2 Sales Results
View All ReportsStreetInsider.com Reports on CSCX
- Cardiac Science Corp. (CSCX) Announces Correction of Faulty AED Components
- Cardiac Science (CSCX) Reports Large Q3 Loss; Issues Mixed Guidance for Q4
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- After-Hours Movers 8/10: SDTH, LGF, ARRY, RAX Higher; BIDZ, FRPT, CPST Lower
- Cardiac Science (CSCX) Misses Q2 EPS by 4c; Guides Below for Q3
View All Press ReleasesCompany Press Releases on CSCX
- Cardiac Science Notifies AED Customers of Nationwide Voluntary Medical Device Correction
- Cardiac Science and Cambridge Heart Announce Development Partnership
- Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing
- Cardiac Science Announces Third Quarter Results
- Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
StreetInsider Reports on CSCX by Category
View All BlogsBlogs on CSCX
- Cardiac Science Corporation F4Q08 Earnings Call Transcript
- Cardiac Science Corporation Q2 2008 Earnings Call Transcript
- Cardiac Science Corporation: Shares forming a bullish "flag" pattern
View All FilingsSEC Filings on CSCX
- Form 4 Cardiac Science CORP For: Nov 16 Filed by: Kingma Peter
- Form 10-Q Cardiac Science CORP For: Sep 30
- Form 8-K Cardiac Science CORP For: Nov 09
- Form 4 Cardiac Science CORP For: Nov 06 Filed by: DAVIS CHRISTOPHER J
- Form 8-K Cardiac Science CORP For: Nov 05
Comments on CSCX
No comments are currently available.
